Medical Youth for Head and Head Cancer

Recent medical records show a one - year increase in survival from 16 percent to 36 percent of patients who are not treated with surgery or radio therapy.

Immunosis can be the new key to fighting head and neck tumors.

These drugs, which will arrive in Italy until summer, operate on the immune system by stimulating a positive response. These are therapies that have as their first objective not the disease itself but the strengthening of individual immunity.

These are innovative drugs, proven, tested, and some of them have even been approved by the regulatory bodies, states Professor Lisa Licitra, director of Medical Oncology at the National Cancer Institute in Milan. It has, in fact, been confirmed, the benefit for patients using these new molecules in certain particular situations such as repeated diseases.

”Objective for the future remains to use these drugs in curable diseases, to use them in advanced local diseases or even at an early stage for cancer cases in the head and neck”, said Licitra Professor at the seminar held in Milan on the subject of the elderly patient: challenges of a multidisciplinary approach and tumors in the head and neck.

Incompatible drugs have proved to last for survival. These drugs are approved by the respective institutions and is waiting for the latest processing of which age they will use and at what stage of the disease. In Italy their approval is expected in the summer of 2018.

In the tumors already treated with chemotherapy, these immunotherapeutic drugs will be considered the state of art, so they will replace the actual ones. The data shows a year-on-year increase in survival by 16 percent of standard therapy in 36 percent using biological drugs.

The risk factors for these drugs are that, the elderly “person, especially if he lives alone and is not independent, is more likely to be unable to observe a therapeutic protocol ) explains Professor Licitra lysia, in fact, leads to complete isolation and therefore in a lack of desire to react to the disease and face therapy. But there are other problems that cause worse health conditions - an uncertain economic situation, depression, and other diseases besides tumors. Gina also affects because women survive more than men, perhaps because they are less exposed to risk factors.

What are tumors on the head and the neck

Head and neck tumors almost exclusively affect adults, especially males. Despite its rare cancer, compared with the ten most frequent in the Italian and European population, it is necessary to keep control especially over the years. Today, in Italy there are 9,500 cases a year, 7,200 men are concerned, 2300 women. Moreover, in recent months there has been a decline in human mortality. This data remains consistent with women. Average survival in one year is about 80 percent, which is reduced to less than 60 percent in 5 years. Head tumors refer to the group of Neoplasmas coming from the nostrils and hollow, larynx, and saliva glands. The most common, about one in two cases, is the larynx, followed by the hollow in the mouth and throat. 90 percent of these tumors are spino-cellic cancers; the rest, has to do with melanoma, sarcoma, lymphoma, and other types of cancer.